Pay in 4 interest-free payments of $5.21 Learn more
Ships within 48 hours · Estimated delivery Aug 18 - Aug 23
As overcoming these shortages is the only way forward, biotechs are spending on manufacturing to tackle current limitations and refine access as well as to circumvent future scarcity of these drugs that could lower the risk of life-threatening obesity-related complications for millions of people
Organoids were incubated in Cell Recovery solution (354253) for 30 min at 4 C
Dietary intake of vitamin C and gastric cancer: a pooled analysis within the Stomach cancer Pooling (StoP) Project
The investigators of this report specifically chose a sample of younger males (between ages 20 and 39 years) because this is the period when fertility is highest
In May 2026, At the EASL Congress 2026, MetaVia presented promising late-breaking Phase 1 clinical trial results for DA-1726, an investigational dual GLP-1 and glucagon receptor agonist under development for obesity and Metabolic Dysfunction-Associated Steatohepatitis (MASH)
Elife 30(7):e37420 Fan Y, Pedersen O (2021) Gut microbiota in human metabolic health and disease
US$ 21.11
US$ 29.67
US$ 23.35
US$ 21.23
US$ 26.03
